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The membrane-expressed HIV-1 envelope glycoprotein complex, gp120 and gp41, has been shown to be responsible for
the initiation of cell killing by apoptosis in CD4/ T cells. By using two experimental approaches we demonstrate here that
CD26, also known as dipeptidyl peptidase IV (DPP IV), appears to be implicated in this function of the gp120/gp41 complex
to initiate apoptosis. In the first experimental model, we used persistently HIV-1-infected H9/IIIB cells expressing the
membrane-associated gp120/gp41 complex as effector cells to induce apoptosis in Jurkat CD4/ T cells: parental or trans-
fected in order to express high levels of recombinant CD26, either wild-type or mutated at its Ser-630 which inactivates
the DPP IV activity of CD26. Parental Jurkat cells and transfected control cell clones express low but reproducibly detectable
levels of endogenous CD26. In coculturing experiments using H9/IIIB and Jurkat cells, the occurrence of apoptosis was
found to be retarded by at least 24 hr in Jurkat cells expressing low levels of endogenous CD26, compared to cell clones
expressing high levels of either wild-type or mutated catalytically inactive transfected CD26. In the second experimental
model, the different Jurkat cell lines were infected with vaccinia recombinant viruses expressing HIV-1 env gene, either
wild-type to generate a functional gp120/gp41 complex or mutated to generate an uncleavable membrane-expressed
precursor of the envelope glycoprotein gp160. At 18 hr postinfection with such vaccinia recombinant viruses, apoptosis
was observed only in Jurkat cells with enhanced levels of CD26 and expressing the gp120/gp41 complex. Apoptosis was
not detected in the different Jurkat cell lines expressing the uncleavable precursor gp160. In both of the experimental
models used, no significant differences were observed between the transfected cells expressing either the wild-type or the
mutated form of CD26, thus suggesting that the DPP IV activity of CD26 is not essential for its function as a cofactor of
CD4 in the mechanism of initiation of apoptosis by the HIV envelope gp120/gp41 complex. Taken together, these results
indicate that CD26 in CD4/ T cells may determine the rate of initiation of apoptosis by the mature HIV-1 envelope glycopro-
teins, i.e., CD26 is being involved as a cofactor of CD4 in the mechanism of triggering apoptosis by the gp120/gp41 complex.
As signaling through CD26 could lead to T cell activation, we propose that this latter might be modified following the binding
of the gp120/gp41 complex to CD4 and thus leading to apoptosis. q 1996 Academic Press, Inc.
INTRODUCTION responsible for the binding of the particles to the cell
membrane and thus initiating virus to cell membrane
The human immunodeficiency virus (HIV) infects T lym- fusion essential for viral entry in CD4/ T cells. In already
phocytes, monocytes, and macrophages by binding to infected cells, the gp120/gp41 complex expressed on
its principal receptor, the CD4 molecule, through its enve- cell membranes and through interaction with cell surface
lope glycoprotein complex (for a review see Moore et CD4 is responsible for the initiation of cell to cell mem-
al., 1993). The HIV-1 envelope gene codes for a precursor brane fusion leading to the formation of syncytia. The
polyprotein gp160 which is processed by proteolytic cell surface expressed gp120/gp41 complex is also re-
cleavage to yield extracellular (gp120) and transmem- sponsible for the initiation of apoptosis in CD4/ T cells,
brane (gp41) envelope glycoproteins. The gp120 contains which could be characterized by different techniques,
the CD4 binding site and the principal neutralization do- such as by the fragmentation of the chromatin into the
main referred as the V3 loop. The gp41 contains a poten- typical oligonucleosomal-length DNA ladder, by the pres-
tial fusion peptide at its amino terminus which is impli- ence of nucleosomal histones in the nucleoplasm, and
cated in the membrane fusion process. The gp120 and by electron microscopy to reveal hypercondensation of
gp41 are associated in a noncovalent manner to gener- the chromatin (Terai et al., 1991; Laurent-Crawford et
ate a complex which has several major functions in HIV al., 1991; Hovanessian, 1994; Martin et al., 1994). The
infection. For HIV particles, the gp120/gp41 complex is occurrence of apoptosis can be reproduced in CD4/ T
cells by the expression of the HIV env gene alone to
generate the mature envelope glycoproteins, i.e., the1 To whom correspondence and reprint requests should be ad-
gp120/gp41 complex (Laurent-Crawford et al., 1993;dressed at Unite´ de Virologie et Immunologie Cellulaire, Institut
1995). Besides T cell lines, CD4/ but not CD8/ bloodPasteur, 28, rue du Dr. Roux, 75724 Paris ce´dex 15, France. Fax:
(33.1)40.61.30.12. lymphocytes have been reported to undergo rapid cell
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death in vitro by contact with autologous HIV-infected al., 1995; Callebaut and Hovanessian, 1996; Callebaut et
al., 1996).cells expressing the gp120/gp41 complex (Nardelli et al.,
1995). With respect to HIV infection in AIDS patients, it has
been demonstrated that in contrast to other activationThe initiation of syncytium formation and apoptosis
appears to exert similar requirements, such as cleavage molecules like CD38, HLA-DR (Kestens et al., 1994), the
expression of CD26 on T lymphocytes is decreased inof the precursor gp160 to yield the mature gp120 and
gp41 products, membrane expression of the gp120/gp41 HIV seropositive individuals during the progression to-
ward AIDS (De Pasquale et al., 1989; Valle-Blazquez etcomplex, interaction of this complex with CD4 receptor
molecules, and a functional V3 loop (Laurent-Crawford al., 1992; Vanham et al., 1993), and this latter appears to
be selective for the CD4//CD26/ T cell subset (Gougeonet al., 1995, 1993). In spite of this however, the occur-
rence of apoptosis is not a consequence of syncytium et al., 1996a). Furthermore, the depletion of CD26 ex-
pressing cells appears not to be correlated with the ex-formation. Indeed, in cultures infected with a syncytium-
inducing (SI) HIV isolates, apoptosis is observed in both pression of Fas antigen (CD95/Apo-1; Gehri et al., 1996).
Here we demonstrate that the level of CD26 in CD4/syncytia and in single cells (Corbeil and Richman, 1995;
Laurent-Crawford et al., 1993). Furthermore, single cell Jurkat cells could be a determining component for the
rate of the gp120/gp41 complex-mediated initiation ofkilling by apoptosis is also observed in CD4/ T cells
infected with non-syncytium-inducing HIV isolates (Rey- apoptosis. Systematically, we observed a significant de-
lay in the induction of apoptosis in Jurkat cell lines ex-Cuille´ et al., 1994). With both SI and NSI phenotypes of
HIV, anti-CD4 antibodies that block interaction with the pressing low levels of CD26 compared to those express-
ing high levels of CD26. The delay in the induction ofexternal envelope glycoprotein inhibit the initiation of
apoptosis. Thus indicating that the initiation of apoptosis apoptosis was not observed in the low CD26 expressing
cells, when apoptosis was triggered with anti-Fas mono-requires first the interaction of the cell surface-expressed
external HIV envelope glycoprotein with the CD4 recep- clonal antibody in the different Jurkat cell lines. These
observations indicate that the delay in the induction oftor, before triggering directly or indirectly a signal trans-
duction pathway (Tian et al., 1996; Maldarelli et al., 1995). apoptosis is not an intrinsic property of the low CD26
expressing cell lines, but it is a consequence of a lesserSeveral reports have suggested that although the CD4
molecule is essential for binding HIV particles, it is not efficacy of events associated with the functioning of the
gp120/gp41 complex when the expression of CD26 issufficient for HIV entry and infection. Consequently sev-
eral candidates have been proposed (reviewed in Moore low. Previously, several reports have indicated that sig-
naling through CD26 could lead to T cell activation (re-et al., 1993; Sato et al., 1994; Dukes et al., 1995). We
have previously reported that the T cell-activation antigen viewed in Fleischer, 1994). Consequently, it is possible
to suggest that the interaction of the gp120/gp41 complexCD26, also known as dipeptidyl peptidase IV (DPP IV),
may serve as a cofactor of HIV entry in CD4/ cells with CD4 is followed by a modified CD26 signaling, which
might then be responsible for the initiation of apoptosis.(Callebaut et al., 1993). However, using other experimen-
tal approaches, other groups have contested our find- Whatever is the case, our results suggest that the costi-
mulatory molecule CD26 is involved as a cofactor of CD4ings; their critics and our response have been published
(Broder et al., 1994; Callebaut et al., 1994a). Recently, in the mechanism of triggering apoptosis by the gp120/
gp41 complex.more evidence in favor of the role of CD26 in HIV infection
has been provided by several observations reported by
two independent groups (Oravecz et al., 1995; Chin et MATERIALS AND METHODS
al., 1995). On one hand, the role of CD26 along with the
Cells
V3 loop was emphasized for HIV entry and its cytopathic
effect, and on the other hand, a V3 loop peptide was Jurkat cells (referred to as JBK) and MOLT4-T4 (clone
8) cells derived from MOLT4 cells were provided by Dr.shown to bind a synthetic CD26 peptide containing the
consensus sequence G-X-S-X-G found in all serine prote- L. Montagnier, Institut Pasteur, France. Jurkat cells, pa-
rental (clone P32) and transfected in order to expressases, including CD26. In addition, the second comple-
mentarity determining region (CDRH2) of the heavy chain human CD26, either wild-type (clones J37 and 11 referred
to as T11) or with a point mutation in the serine-630 intoof an HIV-1 neutralizing antibody, the epitope of which
is localized in the V3 loop, was found to contain a short alanine (clones D28 and 3/13) were provided by Dr. C.
Morimoto, Dana-Farber Cancer Inst. (Boston, MA) (Ta-stretch of amino acids homologous to the characteristic
serine protease consensus sequence of CD26 (Chin et naka et al., 1993). Jurkat control clones JC31 and JC35
were generated by transfection of parental Jurkat JBKal., 1995). Consistent with the involvement of CD26 in the
mechanism of HIV entry, recent works have confirmed cells with pNeoSRaII plasmid containing the SRa pro-
moter (20 mg of DNA for 107 cells; the plasmid was ob-that an enhanced but physiologically balanced expres-
sion of CD26 in human cell lines increases the rate of tained from U. Blank, Institut Pasteur) and selected with
geneticin (1.2 mg/ml). Chronically HIV-1-infected H9/IIIBHIV entry by 24 to 48 hr compared to their corresponding
counterparts expressing low levels of CD26 (Oravecz et cells were obtained from Dr. R. C. Gallo (National Institute
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of Health, Bethesda, MD). All cells were cultured in sus- Labeling of Jurkat target cells with 5-[125I]iodo-2*-
deoxyuridinepension medium RPMI 1640 (Bio-Whittaker, Verviers, Bel-
gium) containing 10% (v/v) fetal calf serum.
Jurkat cells (at 106 cells/ml) were labeled with 125I-IUdR
(Amersham; 20 mCi/ml) for 6 hr at 377 (Razvi and Welsh,Coculturing of chronically infected cells with
1993). Cells were then washed once in culture mediumuninfected CD4/ T cells
to remove excess isotope, and cells were recultured for
In a typical coculturing experiment, 0.5 1 106 chroni- 18 hr. Such labeled target cells were then processed for
cally infected H9/IIIB cells (effector cells) were mixed the coculturing experiment by mixing with chronically
with 5 1 106 Jurkat cells in 10 ml of culture medium infected effector cells (as above). Nuclear extracts were
(RPMI 1640 containing 10% fetal calf serum). The cocul- prepared as described and assayed for apoptosis (by
tures were incubated at 377 and monitored for the devel- the presence of nucleosomal histones and by the typical
opment of the cytopathic effect manifested by syncytium DNA ladder; see section on ‘‘Detection of Apoptosis’’).
formation and ballooning of cells. The agarose DNA gels were transferred to nylon mem-
branes (Hybond N/; Amersham) and the DNA pattern
Preparation of cell extracts was revealed using a Phosphorimager (Molecular Dy-
namics, Sunnyvale, CA).Cells were washed with phosphate-buffered saline
125I-IUdR being incorporated into the chromatin, con-(PBS) before disruption in cytoplasm extraction buffer
trol cells in principal should not contain radioactivitycontaining 20 mM Tris–HCl (pH 7.6), 0.15 M NaCl, 5 mM
in the nucleoplasm. However, as a consequence ofMgCl2 , 0.2 mM phenylmethylsulfonyl fluoride (PMSF),
apoptosis-induced cleavage of the chromatin, nucleo-100 units/ml aprotinin (Iniprol), and 0.5% Triton X-100.
somal fragments are recovered in the nucleoplasmAfter centrifugation at 350 g, the supernatant contained
fraction, and thus the 125I-IUdR-labeled LMW DNA/his-the cytoplasm, whereas the intact nuclei were pelleted.
tone complex could be quantitated by measuring theThe nuclei were then extracted in lysis buffer containing
amount of radioactivity. In view of this, 1- to 5-ml ali-10 mM Tris–HCl (pH 7.6), 0.4 M NaCl, 1 mM ethylenedi-
quots of the nucleoplasm preparations were appliedaminetetraacetic acid (EDTA), 0.2 mM PMSF, aprotinin
to 2.5-cm filter discs (Whatman 3MM paper), washed(100 units/ml), and 1% Triton X-100. Nuclear extracts were
with cold 5% trichloroacetic acid (15 min), and washedcentrifuged at 12,000 g to pellet the high-molecular-
subsequently with ethanol, ethanol/acetone (1/1; v/v),weight (HMW) chromatin; the supernatants constituted
and acetone at room temperature. The filters werethe nucleoplasm of cells (Laurent-Crawford et al., 1993).
dried and the radioactivity was measured by a gamma
Detection of apoptosis counter (CLINIGAMMA 1272, LKB).
Apoptosis was monitored by analyzing both DNA frag-
Vaccinia virus recombinantsmentation and the presence of nucleosomal histones in
the nucleoplasm of cells, as described previously Vaccinia virus (VV) expressing HIV-1 Lai env gene was
(Laurent-Crawford et al., 1993, 1995). Apoptotic cells con- used: either the wild-type env gene (VVTG 9.1) to gener-
tain low-molecular-weight (LMW) DNA in the nucleo- ate a gp160 precursor which is then cleaved into gp120
plasm. This LMW DNA was extracted with phenol/chloro- and gp41 or mutated at the gp120 to gp41 cleavage site
form/isoamyl alcohol before electrophoresis on 1.4% (VVTG 1139) to generate an uncleavable gp160 precursor
agarose gels containing ethidium bromide to reveal the (Kieny et al., 1986; 1988). Cells were infected with these
typical LMW DNA ladder made up of multimers of a VV recombinants at 50 PFU/cell and apoptosis was as-
nucleosomal length unit of about 180-bp DNA. For analy- sayed at 18 hr postinfection (p.i.) as described before
sis of nucleosomal histones (histone octamer made up (Laurent-Crawford et al., 1993). The VV recombinants
of two molecules each of H2A, H2B, H3, and H4), the were provided by M. P. Kieny (Transgene, Strasbourg,
nucleoplasm was treated with an ionic detergent, such France).
as SDS, to solubilize the histone octamer associated with
the LMW DNA. For this purpose aliquots of the nucleo- Monoclonal antibodies
plasm were diluted onefold in the electrophoresis sam-
ple buffer (0.125 M Tris–HCl, pH 6.8, 2% w/v SDS, 20% Three different monoclonal antibodies (mAbs) specific
to CD26 were used: mAb BA5, IgG2a from Immunotechglycerol, and 1% b-mercaptoethanol) and boiled 5 min
before analysis by polyacrylamide gel (15%) electropho- S.A. (Marseille); mAb Ta1, 4EL-1C7 IgG1 from Coulter
(Miami, FL); and mAb 1F7 IgG1, a generous gift of Dr. C.resis in SDS. The histone bands were revealed by stain-
ing the gel with Coomassie blue. Material corresponding Morimoto (Dana-Farber Cancer Inst., Boston, MA; Dang
et al., 1990b). Two different mAbs specific to CD95 (Fas/to 2 and 0.5 1 106 cells was used for DNA fragmentation
and histone analysis, respectively. In the absence of Apo-1) were purchased from Immunotech S. A. Marseille:
mAb UB2, IgG1 that does not induce apoptosis and mAbapoptosis, very little, if any, LMW DNA or histones are
observed in the nucleoplasm of cells. CH11, IgM that induces apoptosis in CD95/ cells (Oga-
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sawara et al., 1993). The mAbs OKT4 (IgG1) and OKT4A cell lines (independent of the level of CD26 expression)
incubated with either 10 or 100 ng/ml of mAb CH11. On(IgG1) specific to CD4 were from Ortho Diagnostics Sys-
tems. The mAbs G44-26 (IgG2b, K) and M-T701 (IgG1) the other hand, no apoptosis was observed in the differ-
ent Jurkat cell lines incubated with 1 mg/ml of mAb UB2specific to CD44 and CD7, respectively, were from Phar-
migen. MAbs IOT 16 (IgG1) and UCHL1 (IgG2a) specific specific to CD95 but known as a noninducer of apoptosis.
to CD11a and CD45RO, respectively, were from Immuno-
tech S.A. The mAb B4 (IgG1) specific for CD19 was from Quantitation of apoptosis
Coulter. MAb 110/4 specific to the V3 loop of gp120 and
We have previously demonstrated that detection ofmAb 25/3 specific to p24 (HIV-1 major core protein) were
nucleosomal histones is a convenient assay for monitor-obtained from Genetic Systems (Seattle, WA).
ing apoptosis (Laurent-Crawford et al., 1991, 1993, 1995).
By our experimental procedure for preparing the nucleo-Detection of cell surface antigens
plasm fraction from apoptotic cells, the undegraded chro-
Cells were incubated with fluorescein isothiocyanate matin is conveniently separated from the degraded
(FITC)- or phycoerythrin (PE)-labeled mAbs in PBS con- nucleosomal LMW DNA which represents LMW DNA
taining 1% bovine serum albumin (BSA) and 0.01% so- associated with the histones. The LMW DNA can be
dium azide at 47 for 30 min. The cells were then washed extracted and analyzed by gel electrophoresis to reveal
twice with PBS and fixed in 1% formaldehyde in PBS. In the typical DNA ladder, whereas histones can be directly
all experiments, PE-labeled mAb B4 specific for CD19 solubilized in SDS and assayed by polyacrylamide gel
(Coulter) was used as a control for PE-labeled mAbs electrophoresis. The assay of apoptosis by the detection
Ta1 (Coulter) and BA5 (Immunotech), and FITC-labeled of histones can reveal very low levels of apoptosis. This
mouse isotype control antibody MCG1 (IgG1) as a control technique therefore is sensitive, and furthermore the re-
for FITC-labeled mAbs B-F5, IgG1 specific to CD4 (both sults obtained are highly reproducible.
from Immuno Quality Products), and UB2 specific to The region containing the stained histone bands (H2A,
CD95 (Immunotech). The FITC- or PE-labeled cells were H2B, H3, and H4) were scanned using a StudioScan II
applied to a FACScan flow cytometer (Becton–Dickinson, (AGFA) apparatus, in order to estimate by quantitative
Mountain View, CA). For each sample, 10,000 cells were densitometry the amount of histones present in a given
analyzed with lysis II Software (Becton–Dickinson). sample. The values (V) represent number of elements (1
element  number of pixels 1 100 mm) as determined
Immunoblot analysis by the Image-Quant (Molecular Dynamics, Sunnyvale,
CA). The degree of apoptosis was calculated accordingCrude cytoplasmic extracts were diluted 1-fold in elec-
to the following formula: % Apoptosis  [(VS 0 VB)/(VM 0trophoresis sample buffer and analyzed by SDS–poly-
VB)] 1 100; where VS stands for the value obtained withacrylamide gel electrophoresis before electrophoretic
the sample in question, VB stands for the backgroundtransfer to 0.45-mm Immobilon-P sheets (Millipore). The
value (i.e., spontaneous apoptosis) observed in the con-electrophoretic blots were saturated with 5% (w/v) nonfat
trol sample without specific induction of apoptosis, anddry milk in PBS. They were incubated with different anti-
VM stands for the maximum level of apoptosis observedbody preparations in PBS containing 10% fetal calf serum.
in the Jurkat cells (clone J37) after 16 hr of incubationThe sheets were subsequently washed in PBS and in
with the anti-Fas antibody mAb CH11 (100 ng/ml).PBS containing 5% nonfat milk. The murine antibodies
were revealed with goat anti-mouse immunoglobulin,
whereas human antibodies were revealed with protein RESULTS
A, both labeled with horseradish peroxidase (ECL; Amer-
Expression of CD26 in Jurkat cellssham). In the coculturing experiments, using chronically
infected cells with uninfected CD4/ T cells, at least 5- CD26 as other members of the serine protease family
to 10-fold increased levels of viral proteins are detectable contains the consensus sequence G-X-S-X-G (G for gly-
at 24 hr compared to that detectable in the chronically cine, S for serine, X for any other amino acid) at its cata-
infected cells alone. This latter was completely abolished lytic site, and point mutation of the serine residue to
in the presence of 5 mM AZT, thus confirming that it was alanine causes inactivation of the DPP IV activity
due to infection of the uninfected CD4/ T cells which (Fleischer, 1994). In this study we used parental Jurkat
were used as target cells in the coculture. cells (clone P32) or those transfected with the SRa pro-
moter containing plasmids expressing human CD26, ei-
Induction of apoptosis by anti-Fas antibody
ther the wild-type (clones J37 and T11) or mutated at the
serine-630 residue (clones D28 and 3/13; Tanaka et al.,Jurkat cell lines (3 1 106 at 106/ml) were incubated
with mAb CH11 specific to CD95 or Fas at 377 for 16 hr. 1993). Additional control Jurkat cells included in this
study were JBK cells and the transfected clones JC31Apoptosis was then monitored by assaying histones in
the nucleoplasm fractions. Under these experimental and JC35 with a plasmid containing the SRa promoter
without the CD26 cDNA.conditions, apoptosis occurred in all the different Jurkat
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ancy is most probably due to the culturing conditions of
these Jurkat cell lines, since our cells were of the same
origin as those of Morimoto and collaborators (Tanaka
et al., 1993). As the expression of CD95, the expression
of other cell surface antigens, such as CD45RO, CD7,
CD44, and the chain CD11a of LFA-1, were not signifi-
cantly different between the different Jurkat cell lines (not
shown; Materials and Methods). The CD7 and CD44S
antigens have been implicated in HIV entry, whereas
LFA-1 has been implicated in the cell/cell membrane
fusion process (Sato et al., 1994; Dukes et al., 1995; Pan-
taleo et al., 1991).
The occurrence of apoptosis in cocultures of
chronically HIV-1-infected cells with uninfected CD4//
CD26/ MOLT4-T4 cells
Previously, we have reported that transfected human
HeLa cells with the HIV-1 env gene (in order to express
the membrane-associated gp120/gp41 complex) could
be used as effector cells to induce apoptosis in unin-
fected CD4//CD26/ MOLT4-T4 cells (Laurent-Crawford
et al., 1995). Here, instead of transfected HeLa cells,
we used chronically HIV-1-infected H9/IIIB cells. These
chronically infected cells produce HIV-1 particles and
therefore express envelope glycoproteins associated
with the cell membrane. However, because of severe
down-regulation of their CD4 receptors, chronically in-
FIG. 1. Cell surface expression of CD26 in different Jurkat cell lines fected cells do not by themselves undergo cell/cell fusion
and in MOLT4-T4 cells. FACS analysis of cell lines was carried out and apoptosis (Laurent-Crawford et al., 1991). In a typical
using PE-labeled mAbs BA5 and TA1 specific for CD26 and PE-labeled
experiment, coculturing of chronically infected cells withmAb B4 specific for CD19 as a control (indicated as the peak C-PE for
a 10-fold excess of uninfected MOLT4-T4 cells results ineach cell type). The Jurkat cells were the following: low endogenous
CD26 expressing cells (the parental P32 and JBK cells) and high recom- cell/cell fusion monitored by syncytium formation within
binant CD26 expressing cells, either wild-type CD26 (clones J37 and a few hours. Coculturing also leads to cell/cell HIV trans-
T11) or mutated at its Ser-630 (clone D28). mission (Sato et al., 1992). At 16 to 20 hr, apoptosis is
clearly observed, monitored by the presence of the his-
tone octamer (H2A, H2B, H3, and H4) in the nucleoplasm
The parental Jurkat cell lines, in general, are consid-
and also by the typical fragmentated LMW DNA ladder.
ered CD26 negative in comparison to cells expressing
high levels of CD26. However, it should be emphasized The level of CD26 determines the rate of apoptosis
that these cells do express low levels of CD26 which
could be detected by fluorescence-activated cell sorting Cocultures of the chronically infected cells and the
different Jurkat cell lines, at a ratio of 1 to 10, were investi-(FACS) analysis using different monoclonal antibodies
specific to CD26, mAb BA5 and Ta1 (Fig. 1). An observa- gated for the occurrence of apoptosis by assaying the
presence of nucleosomal histones and the fragmentatedtion which has been confirmed by the detection of CD26
mRNA (Werner, et al., 1994; and unpublished data) and nucleosomal-length DNA ladder in the nucleoplasm frac-
tions of such cocultured cells (Fig. 2). The histones wereby an immunoblot assay using mAb 1F7 specific to CD26
(Blanco et al., 1996; Jacotot et al., 1996). As expected the detected as soon as 18 hr post-coculturing with Jurkat
cell lines expressing the recombinant forms of CD26 withexpression of CD26 was enhanced considerably in the
recombinant CD26 expressing clones (Fig. 1). maximum levels at 36 hr (Fig. 2A, panels J37 and D28). In
the coculture with the parental Jurkat cell line, however,Recently, Morimoto et al. (1994) have reported that the
parental Jurkat cell line (P32) and clones expressing the histones were not detectable before 36 hr (Fig. 2A, panel
P32), and even then, their level was found to be lowerrecombinant mutant form of CD26 (D28, 3/13) express
higher levels of CD95 (Fas) than the clones expressing than that observed in the cocultures with the recombinant
CD26 expressing cells. The presence of histones wasthe recombinant wild-type CD26 (J37, T11). In contrast to
this, we did not detect any apparent difference in the indeed the consequence of the specific fragmentation
of the chromatin associated with apoptosis, which wasexpression of CD95, which was identical in the different
clones (not shown; Materials and Methods). This discrep- illustrated by the presence of typical LMW DNA ladder
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found also to be delayed in Jurkat clones obtained by
transfection with a similar plasmid containing the SRa
promoter. A typical result is shown in Fig. 3. Clearly, no
apparent differences were observed between the rate of
apoptosis in the transfected clone JC31 and its corre-
sponding untransfected Jurkat JBK cells.
Characterization of apoptosis in cocultures of H9/IIIB
and Jurkat cells
For further characterization of the occurrence of
apoptosis in cocultures of H9/IIIB with Jurkat cells, we
investigated the effect of three reagents: (1) the reverse
transcriptase inhibitor AZT which blocks new HIV infec-
tion as a consequence of cell/cell spreading of virus
(Sato et al., 1992); (2) the monoclonal antibody mAb
OKT4A which is directed against the gp120 binding site
in the CD4 molecule (Sattentau and Weiss, 1988); and
(3) ZnSO4 , an inhibitor of the nuclear endonuclease(s)
responsible for fragmentation of cellular DNA during
apoptosis (Arend et al., 1990). In view of these experi-
ments, we used cocultures of H9/IIIB cells with the re-FIG. 2. The occurrence of apoptosis in cocultures of uninfected Jurkat
combinant CD26 expressing cell line J37, which result incell lines with chronically HIV-1-infected cells. Coculturing of the differ-
ent Jurkat cell lines with the chronically infected H9/IIIB cells was at the generation of syncytia and the occurrence of clearly
a ratio of 10 to 1, with a final concentration of cells at 1 1 106 cells/ observed apoptosis at 24 hr. AZT blocked completely
ml of culture medium. Apoptosis was monitored at time 0 (to estimate cell/cell spreading of HIV infection, monitored by the lack
the background in each cell line) and at 18, 24, and 36 hr post-cocultur-
of enhanced synthesis of viral proteins (assayed by im-ing by assaying the nucleoplasm fractions for the presence of histones
munoblotting using HIV-1 positive human serum; Materi-H2A, H2B, H3, and H4 (section A) and LMW DNA (section B). Jurkat
cells were the following: P32, parental cells, J37 and D28, wild-type als and Methods). Interestingly, in the presence of AZT,
and mutated CD26 expressing cells. Lane M in section A shows the no apparent modification was observed in the formation
profile of molecular weight protein markers. In section B, lanes on the of syncytia and induction of apoptosis (Fig. 4, compare
left and on the right side of the gel represent the profile of a 100-bp
lanes 2 and 3; 0 or / AZT at 24 hr), thus suggestingladder of DNA and the l/HindIII DNA marker, respectively.
that these events are due to the viral envelope gp120/
gp41 complex already expressed on the surface of the
chronically infected cells and not due to new infection.corresponding to the nucleosomal-length DNA fragments
(Fig. 2B). Addition of mAb OKT4A blocked both syncytium forma-
tion and apoptosis, thus confirming that initiation of theseThe delay in the occurrence of apoptosis in cocultures
of H9/IIIB cells with the low CD26 expressing Jurkat P32 events requires first the interaction of gp120 to the CD4
molecule (Fig. 4, lane OKT4A). Finally, consistent withcells was reproducibly observed in several independent
experiments. The results shown in Fig. 3 illustrate by a the role of the endonuclease in the apoptotic process,
ZnSO4 blocked apoptosis without any apparent effect onquantitative analysis (Materials and Methods) that the
occurrence of apoptosis is delayed at least 24 hr in the syncytium formation. This latter observation also illus-
trates once again that apoptosis is not a direct conse-cocultures with the low CD26 expressing Jurkat cell lines
(JBK, P32, JC31) compared to Jurkat cell lines expressing quence of syncytium formation, as has been pointed out
before (Laurent-Crawford et al., 1993; Rey-Cuille´ et al.,enhanced levels of recombinant CD26, either wild-type
(T11, J37) or mutated (D28). Furthermore, the DPP IV ac- 1994; Corbeil and Richman, 1995). These different char-
acteristics of apoptosis shown in Fig. 4 are very similartivity of CD26 is not required for its function in the occur-
rence of apoptosis in such cocultured cells (Fig. 3; see to what has been reported recently in cocultures of H9/
IIIB and H9 cells (Maldarelli et al., 1995).also below).
The high CD26 expressing cell lines were generated In order to demonstrate that DNA fragmentation did
occur in the uninfected Jurkat cells during the coculturingby transfection of Jurkat cells with the plasmid pSRa,
expressing either the wild-type or mutated form of CD26 with the chronically infected cells, the chromatin of Jurkat
cells (clone J37) was 125I-labeled by first labeling cells(Tanaka et al., 1993). Consequently, it could be argued
that transfection of Jurkat cells with the plasmid alone with 125I-IUdR (a DNA precursor) before incubation with
the chronically infected cells (Materials and Methods).could trigger phenotypic modifications resulting in a
more rapid induction of apoptosis. This possibility, how- This procedure, although was effective for labeling of the
chromatin, had serious side effects. Indeed, in contrastever, is most unlikely, since the rate of apoptosis was
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FIG. 3. Enhanced expression of CD26 is correlated with an increased rate of HIV-mediated apoptosis. The coculturing conditions were as in Fig.
2. At time 0 (to estimate the background in each culture) and 18, 24, and 36 hr post-coculturing, nucleoplasm fractions were assayed for the
presence of histones to monitor apoptosis. The percentage of apoptosis was estimated by quantitative densitometry of stained histones corresponding
to H2A, H2B, H3, and H4 as described under Materials and Methods. Jurkat cell lines were the following: low endogenous CD26 expressing cells
(parental JBK and P32 cells or the control transfected JC31 clone) and high recombinant CD26 expressing cell lines, either wild-type CD26 (clones
T11 and J37) or mutated at its Ser-630 (clone D28).
to unlabeled cells (Fig. 5A, lane 1), 125I-IUdR-labeled cells occurring in cocultured cells (Fig. 5, lanes 4). Intriguingly,
heparin also blocked the spontaneous apoptosis oc-manifested a significant level of spontaneous apoptosis
demonstrated by the presence of the nucleosomal his- curring in 125I-IUdR-labeled cells (Fig. 5, lanes 5), the
mechanism of which remains to be determined. Thesetones, the typical labeled-LMW DNA ladder, and in-
creased amounts of radioactivity in the nucleoplasm frac- experiments illustrate that apoptosis occurring in cocul-
tures of target Jurkat cells with chronically infected ef-tion (Fig. 5, lanes 2). In spite of such spontaneous
apoptosis in the cocultured cells, there was an increased fector cells indeed occurred in the target cells. The close
correlation between the intensity of nucleosomal histonedegree of apoptosis over the background level, which
was clearly demonstrated by the 125I-labeled DNA ladder bands with the amount of radioactivity and 125I-labeled
LMW DNA provide further confirmation that the assay ofand the nucleosomal histones (Fig. 5, lanes 3). We have
previously reported that heparin and other polyanions histones is a sensitive, reliable, and efficient experimen-
tal technique for monitoring apoptosis.are potent inhibitors of HIV entry, by blocking a post-
(gp120-CD4)-binding event (Krust et al., 1993). Here we It should be pointed out that 125I-IUdR-labeled cells
could be used to demonstrate the cleavage of the chro-show that heparin is also a potent inhibitor of apoptosis
matin in studies concerning apoptosis. However, the rou-
tine usage of this experimental approach presents seri-
ous limitations because of the spontaneous cleavage of
the chromatin in labeled cells. This latter is most proba-
bly due to the cytotoxicity exerted by the isotope itself,
the cause of which has been reported to be radiological
rather than chemical (Hagmar and Ryd, 1982).
The DPP IV activity of CD26 does not appear to be
implicated in its function in the HIV envelope-initiated
apoptosis
The results presented in Fig. 3 demonstrated that in-
creased rate of apoptosis is observed in cell lines ex-
FIG. 4. The occurrence of apoptosis in cocultures of uninfected Jurkat pressing enhanced levels CD26, either wild-type (clones
J37 and chronically HIV-1-infected cells. Chronically HIV-1-infected, H9/
J37 and T11) or the catalytically inactive mutant form ofIIIB cells (0.5 1 106) were cocultured for 24 hr (lanes 2 to 6) with
CD26 (clone D28). This was further confirmed by investi-uninfected Jurkat J37 cells (5 1 106) in the absence or the presence
of the following: AZT (5 mM), anti-CD4 mAb OKT4A, or control mAb B4 gating the rate of apoptosis in an another clone express-
(5 mg/ml), and ZnSO4 (1 mM). Apoptosis was monitored by assaying ing the catalytically inactive mutant form of CD26 (clone
the nucleoplasm fractions for the presence of histones. Syncytium for- 3/13). Once again, a significant degree of apoptosis was
mation was monitored at 24 hr and it is indicated as 0 or /. Lane 1
observed at 24 and 36 hr in this Jurkat clone expressingrepresents a sample of the coculture extracted at once (without incuba-
a high level of CD26, as was previously observed in othertion) to estimate the background level of histones. Lane M shows the
profile of molecular weight protein markers. A photograph is shown. high CD26 expressing Jurkat clones (J37, T11, and D28),
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FIG. 6. Increased rate of HIV-mediated apoptosis in Jurkat cells ex-
pressing high levels of catalytically inactive form of CD26. Coculturing
of the Jurkat cells expressing either low levels of CD26 (P32) or a high
but catalytically inactive form of CD26 (clone 3/13) with the chronically
infected H9/IIIB cells was at a ratio of 10 to 1, as in Figs. 2 and 3.
Apoptosis was monitored at time 0 (to estimate the background in each
cell line) and 24 and 36 hr post-coculturing by assaying the nucleo-
plasm fractions for the presence of histones H2A, H2B, H3, and H4.
Lane M shows the profile of molecular weight protein markers.
out that the DPP IV activity of CD26 may not be essential
for its function in HIV infection.
The gp120/gp41-induced apoptosis in CD4/ cells is
correlated with the enhanced expression of CD26
In order to evaluate the role of CD26 in the function
of the gp120/gp41 complex to trigger apoptosis, the HIV-
1 env gene was expressed in human CD4/ Jurkat cell
lines expressing low endogenous CD26 (clones JC31 and
P32) or high recombinant CD26, either the wild-type
(clone J37) or mutated at its Ser-630 (Clone D28). For thisFIG. 5. The occurrence of apoptosis in target cells under the cocultur-
purpose, Jurkat cell lines were infected with vacciniaing conditions. Jurkat J37 cells (5 1 106) were labeled with 125I-IUdR
before either culturing alone or as cocultures with the chronically HIV- recombinant viruses (VV) expressing the HIV-1 env gene,
1-infected H9/IIIB cells (0.5 1 106). At 24 hr, apoptosis was monitored either the wild-type (VVTG 9.1) to generate a functional
by assaying nucleoplasm fractions for: (A) the presence of histones (H gp120/gp41 complex or mutated at the cleavage site
indicates their position in the PAGE/SDS gel); (B) the LMW DNA (the
(VVTG 1139) to generate an uncleavable membrane-ex-results obtained by the Phosphorimager are shown; on the left is the
position of the DNA markers in kb); (C) the amount of radioactivity in the
nucleoplasm (1-ml aliquots were counted after 10-fold dilution; abcissa
represents cpm obtained). The different samples numbered as lanes
1 to 5 were the following: lane 1, control unlabeled Jurkat cells; lanes
2 and 5, control 125I-labeled Jurkat cells cultured in the absence (2) or
the presence (5) of heparin (100 mg/ml); lanes 3 and 4, 125I-labeled
Jurkat cells cocultured with H9/IIIB cells in the absence (3) or the
presence (4) of heparin (100 mg/ml). The experimental conditions were
as described under Materials and Methods.
compared to that observed in low CD26 expressing Jur-
kat cell line P32 (Fig. 6).
Lys-[Z(NO2)]-pyrrolidide is a specific inhibitor of the
FIG. 7. Inhibition of the DPP IV activity does not affect the occurrenceDPP IV activity of CD26 with a 50% inhibitory concentra-
of HIV-mediated apoptosis. Coculturing (lanes /) of the Jurkat J37 cells
tion value around 1 mM (Jacotot et al., 1996). Addition expressing high levels of wild-type CD26 with the chronically infected
of this inhibitor at 10 and 25 mM concentrations in the H9/IIIB cells was at a ratio of 10 to 1, in the absence or the presence
of 10 and 25 mM of Lys-[Z(NO2)]-pyrrolidide (panels 0, 10 mM, and 25cocultures of H9/IIIB and J37 cells had no effect on syncy-
mM, respectively). Apoptosis was monitored at 36 hr post-coculturingtium formation and occurrence of apoptosis (Fig. 7). This
by assaying the nucleoplasm fractions for the presence of histonesand the observations showing that cell lines expressing
H2A, H2B, H3, and H4. Lanes: Coculture 0, control Jurkat J37 cells
either the wild-type or the catalytically inactive mutant incubated for 36 hr in the absence or the presence of 10 and 25
form of CD26 are equally effective in the coculture system mM of Lys-[Z(NO2)]-pyrrolidide. Lane M shows the profile of molecular
weight protein markers.to induce rapid syncytium formation and apoptosis point
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syncytia were formed in both low and high CD26 express-
ing cell lines infected with VVTG 9.1 that produces cleav-
able gp160. However, in these latter cultures, a signifi-
cant degree of apoptosis occurred only in Jurkat cell lines
expressing enhanced levels of recombinant CD26, either
wild-type or mutated (Fig. 8B). Thus, expression of en-
hanced levels of CD26 in Jurkat CD4/ cells appeared to
favor the initiation of gp120/gp41-induced apoptosis, and
the catalytic activity of CD26 was found not to be essen-
tial for this effect.
In this particular experiment, the control J37 Jurkat cell
clone manifested a low level of spontaneous apoptosis.
This was most probably a consequence of cell culturing
conditions and due to slight variabilities in the kinetics
of cell proliferation of the different Jurkat cell clones dur-
ing a given experiment. Accordingly, it was not observed
at other occasions (see experiments in Figs. 4 and 7).
Anti-Fas-induced apoptosis is independent of CD26
Certain mAbs against the Fas cell surface protein, also
known as Apo-1 and CD95, have the capacity to kill cells
by apoptosis (Nagata and Suda, 1995). This property of
FIG. 8. The gp120/gp41-induced apoptosis in Jurkat cells expressing mAb specific for the Fas antigen was investigated on the
high levels of recombinant CD26. The different Jurkat cell lines were different Jurkat cell lines which were shown to express
the following: low endogenous CD26 expressing cells (the control
similar levels of cell surface Fas (not shown). The differ-transfected cell line JC31 and the untransfected parental cells P32);
ent Jurkat cell lines were incubated for 16 hr in the pres-high recombinant CD26 expressing cell lines, either wild-type (clone
J37) or mutated at its Ser-630 (clone D28). Cells were infected with VV ence of 100 ng/ml of the anti-Fas antibody and apoptosis
recombinants expressing the HIV-1 Lai envelope glycoprotein: VVTG was monitored by the assay of nucleosomal histones.
1139 construct expresses gp160 that cannot be cleaved because of The results indicated that all the different Jurkat cell lines,
mutations in the cleavage site; VVTG 9.1 construct produces a gp160
expressing low or high levels of CD26, are susceptibleprecursor which is then cleaved into gp120 and gp41. Cells were in-
to anti-Fas antibody-mediated apoptosis (Fig. 9A). Thefected with these VV recombinants at 50 PFU/cell. At 18 hr p.i., cell
cultures were examined under a light microscope for syncytium forma- kinetics of anti-Fas-induced apoptosis was further inves-
tion (indicated as0 or/) before preparation of cytoplasmic and nuclear tigated in low and high CD26 expressing Jurkat cell lines.
extracts. (A) Immunoblotting was carried out to monitor HIV env gene A typical experiment shown in Fig. 9B demonstrates that
expression using cytoplasmic extracts and mAb 110/4 specific for the
the kinetics of apoptosis in low CD26 (JBK) and highenvelope gp120 (the position of gp160 and gp120 is as indicated on
CD26 (J37) Jurkat cell lines are similar. Taken together,the right). (B) Assay of apoptosis in nuclear extracts was carried out
by monitoring the presence of nucleosomal histones (H2A, H2B, H3, these observations indicate that the delay in the occur-
and H4; a section of the protein-stained PAGE–SDS gel is shown) and rence of apoptosis observed in our experimental models
by the presence of the LMW DNA ladder (an ethidium bromide-stained with the low endogenous CD26 expressing Jurkat cells
gel is shown with the position of the 100-bp DNA ladder and the l/
(Figs. 2, 3, 6, and 8) is not an intrinsic property of theseHindIII DNA markers on the left and on the right, respectively). The
cells to resist apoptosis.control panel represents samples from cells which have not been in-
fected with VV. Material corresponding to 0.5 and 2 1 106 cells were Morimoto et al. (1994) have reported that parental (P32
used for histone and DNA fragmentation analyses, respectively. clone) and mutant CD26 expressing (D28 clone) Jurkat
cells are more sensitive than the wild-type CD26 ex-
pressing (T11 clone) Jurkat cells to the induction of
pressed precursor gp160. At 18 hr p.i., cytoplasmic ex- apoptosis by anti-Fas monoclonal antibody. In our hands,
tracts were analyzed for the expression of the HIV enve- the anti-Fas antibody (mAb CH11, IgM)-induced
lope protein, whereas apoptosis was monitored in the apoptosis was systematically observed in the different
nucleoplasm by two different techniques: by the fragmen- cell lines without any significant difference. The discrep-
tation of the chromatin into a typical oligonucleosomal- ancy between the results of Morimoto et al. and ours is
length DNA ladder and by the presence of nucleosomal most probably a consequence of different cell culturing
histones (Fig. 8). The levels of gp160 and gp120 were and experimental parameters used in the different labo-
found to be similar in the different Jurkat cell lines in- ratories. For example, the anti-Fas monoclonal antibod-
fected with VVTG 1139 and VVTG 9.1, respectively (Fig. ies used in both laboratories were from different sources.
8A). As the recombinant HIV env gene was that of the Furthermore, as CD26 and CD95/Fas are highly regu-
lated cell surface antigens, our experiments were per-HIV-1 Lai isolate with a syncytium inducing phenotype,
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FIG. 9. Anti-Fas-induced apoptosis in Jurkat cells is independent of CD26. (A) Induction of apoptosis in Jurkat cell lines by anti-Fas antibody. Low
endogenous (parental JBK and P32 cells) and high recombinant (T11, J37, D28, 3/13) CD26 expressing Jurkat cell lines were incubated for 16 hr in
the absence (panels Control) or presence of 100 ng/ml mAb CH11 specific to CD95/Fas (panels Anti-Fas). Apoptosis was monitored by the presence
of histones in the nucleoplasm fractions (Materials and Methods). Lanes M show the profile of molecular weight protein markers. (B) Kinetics of
anti-Fas-induced apoptosis. Low and high CD26 expressing Jurkat cell lines (JBK and J37, respectively) were incubated with 100 ng/ml mAb CH11
for 0, 4, 8, and 12 hr. At different times, apoptosis was monitored by the presence of histones in the nucleoplasm fractions.
formed 24 hr after passaging cells systematically. What- was shown to bind a V3 loop peptide corresponding to
ever is the case, under our experimental conditions, we the lymphocytotropic HIV-1 MN isolate (Chin et al., 1995).
show that HIV-mediated apoptosis is delayed in the low We have reported that the monoclonal antibody (mAb)
endogenous compared to the high recombinant CD26 1F7 against CD26 can inhibit HIV-1 entry into the CEM
expressing Jurkat cell lines, whereas the anti-Fas-in- T cell line (Note 32 in reference Callebaut et al., 1994a).
duced apoptosis was not significantly different among With a purified preparation of mAb 1F7, we further con-
these same cell lines. It is also of interest to note that firmed that at 25 to 50 mg/ml of this antibody (unpublished
the mechanism of HIV envelope-mediated apoptosis has results), HIV-1 entry into CEM cells is inhibited signifi-
recently been reported to be different from that of anti- cantly. In contrast to HIV entry, however, mAb 1F7 did
Fas-induced apoptosis (Tian et al., 1996). not affect the occurrence of apoptosis in the coculture
model (not shown). This latter does not rule out the impli-
DISCUSSION cation of CD26 in the apoptotic event, since it could
be accounted for by the existence of slightly differentThe gp120/gp41 complex, by its capacity to bind the
mechanisms responsible for the viral entry and the induc-CD4 molecule on the cell surface, initiates virus/cell
tion of apoptosis (discussed in Callebaut et al., 1994a).membrane fusion to allow HIV entry and cell/cell mem-
A somewhat similar situation was also observed for thebrane fusion to form syncytia and also is responsible for
effect of two anti-V3 loop mAbs capable of blocking HIV-1triggering apoptosis (Moore et al., 1993; Hovanessian,
entry but not the occurrence of apoptosis in the coculture1994). Although initiation of these three processes is de-
system (B. Krust and A. G. Hovanessian, unpublishedpendent on the binding of the gp120/gp41 complex to
results), in spite of the fact that the V3 loop plays a criticalCD4, there are subtle differences between these events
role in both events (Moore et al., 1993; Laurent-Crawford(Callebaut et al., 1994a). For example, not all HIV permis-
et al., 1995).sive cells undergo cell/cell fusion efficiently, even when
The mechanism responsible for the initiation ofinfected with syncytium inducing HIV isolates. Further-
apoptosis in CD4/ T lymphocytes by the membrane-ex-more, the gp120/gp41 complex during entry of HIV parti-
pressed gp120/gp41 complex is still not well understood.cles does not initiate the apoptotic process, whereas
The first step is the interaction of the gp120/gp41 com-the cell membrane-expressed gp120/gp41 complex does
plex on the surface of infected cells with the CD4 mole-(Laurent-Crawford et al., 1993). Previously, CD26 has
cule expressed by uninfected neighboring cells. Thisbeen implicated in entry of HIV and its cytopathic effect
priming event induces a protein tyrosine kinase (PTK)in CD4/ cells (Callebaut et al., 1993; Oravecz et al., 1995),
signaling (Tian et al., 1996), along with the lateral interac-and here we provide evidence to suggest that CD26
tion and the recruitment of membrane-expressed pro-could also be implicated in the initiation of apoptosis. The
teins, including CD3, CD45, and CD26 (Dianzani et al.,catalytic activity of CD26 was found not to be required for
1995). In view of the transductional capacities of theseits potential function in HIV entry (Callebaut et al., 1994b)
membrane antigens (Mustelin, 1994), it is plausible toand induction of apoptosis (Figs. 2, 3, 6, 7, and 8). How-
consider that they could modulate or participate in theever, this does not rule out the hypothesis that the cata-
PTK signaling following the priming step. However, onelytic domain of CD26 could serve as a recognition site
can rule out the implication of a direct signaling pathwayfor the V3 loop in the gp120. Consistent with this, a CD26
peptide containing a part of the catalytic domain of CD26 through the TCR/CD3 complex, at least in a coculture
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experimental model, since cell lines not expressing cell brane-expressed gp120/gp41 complex induces apoptosis
in uninfected cells through cell surface interactions withsurface CD3 can still undergo apoptosis (Tian et al.,
1996). Interestingly, CD26 is physically associated with the CD4 and other cell surface antigens. It should also
be noted that the lack of detection of HIV-infected apo-the membrane-linked tyrosine phosphatase CD45, and
modulation of CD26 with certain anti-CD26 monoclonal ptotic cells could be a consequence of rapid elimination
of HIV producing cells by HIV-specific cytotoxic cell- or/antibodies leads to a comitogenic effect on T cell activa-
tion, a process which is associated with enhanced tyro- and antibody-dependent cellular cytotoxicity responses
(Rivie`re, 1990).sine phosphorylation of the z chain of the T cell receptor
TCR/CD3 complex along with an increased CD4-associ- In addition to the depletion of CD4/ T helper cells
during the evolution of AIDS, evidence has been providedated p56lck tyrosine kinase activity (Dang et al., 1990a;
Torimoto et al., 1991). Moreover, IL2 production via CD26 for an intrinsic defect of such cells to recognize and
respond to ‘‘recall antigens’’ (Lane et al., 1985; Vansignaling requires the expression of a functional TCR/
CD3 complex and the cytoplasmic tail of the z chain Noesel et al., 1990), a property of CD4/ CD26/ T cells
(Morimoto et al., 1989). Interestingly, several groups have(Mittru¨cher et al., 1995). These observations and the fact
that the cytoplasmic tail of CD26 is composed of only six reported a selective decrease in CD26 expressing CD4/
T lymphocytes in HIV-1 infected individuals (De Pasqualeamino acids favor the hypothesis that signaling via CD26
is dependent on its interaction with other membrane- et al., 1989; Valle-Blazquez et al., 1992; Vanham et al.,
1993). Recent work from our laboratory has confirmedexpressed antigens, such as CD45. Thus, the CD26/
CD45 complex through tyrosine kinase-dependent trans- this and demonstrated that the decline of CD26 express-
ing cells is mainly observed in CD4/ but not in CD8/duction pathways (Rudd et al., 1994) may play a regula-
tory role in the T lymphocyte activation process. Although cells (Gougeon et al., 1996a). It is also of interest to note
that adenosine deaminase (ADA) is presented on thethe precise role of CD26 in the mechanism of gp120/
gp41 complex-induced apoptosis remains still undefined, surface of CD26/ cells because CD26 is the ADA binding
protein (Kameoka et al., 1993), and elevated levels ofour results are consistent with the implication of CD26
directly or indirectly in this process. We suggest that the serum ADA have been reported in AIDS patients (Lane
et al., 1985) perhaps as a consequence of depletion ofgp120/gp41 complex modifies the CD4-dependent CD26
signaling pathway and that this perturbation may be an CD4/CD26/ T lymphocytes. Consistent with the in vivo
observations in HIV-infected individuals, CD26 appearsearly event which contributes to the induction of
apoptosis. Consistent with this latter, the phosphoryla- to be implicated in the cytopathic effect of HIV infection
in cell cultures. Indeed, high CD26 expressing cells weretion of the TCR z chain has been reported not to occur
in the coculture experimental model of apoptosis, despite reported to be eliminated preferentially during infection
with monocytotropic HIV-1 isolates (Oravecz et al., 1995),of activation of p56lck and the related tyrosine kinase
p59fyn (Tian et al., 1996). and here we have shown that high CD26 expressing
cells undergo increased rate of apoptosis initiated by aOne of the common characteristics of HIV infection is
the gradual depletion of CD4/ T lymphocytes during the lymphocytotropic HIV-1 isolate. Although several mecha-
nisms could be responsible for the depletion of CD4/development of AIDS, and in general there is a very good
correlation between this depletion and the increase of CD26/T lymphocytes in patients, the in vitro observations
point out the contribution of HIV infection in this selectiveviremia (Schnittman et al., 1990; Piatak et al., 1993; Ho
et al., 1995; Wei et al., 1995). Previously it has been decrease. At this stage we cannot eliminate the involve-
ment of other cofactors to complement the gp120/gp41-pointed out that direct and indirect apoptotic mecha-
nisms induced as a consequence of HIV infection are induced cell killing by apoptosis in CD4/ T cells. What-
ever is the case, our results indicate that CD26 is impli-plausible complementary contributors of CD4 depletion
during the development of AIDS (Ameisen, 1992; cated as a cofactor of CD4 in events associated with the
proper functioning of the gp120/gp41 complex.Gougeon et al., 1993). For example, several groups have
demonstrated that in HIV-infected subjects, CD4/ T lym-
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